Fonte
statnews.com
70articoli totali nell'archivio
Hantavirus risk remains low, CDC says, citing its ‘playbook’ response
Despite rising concern about the hantavirus outbreak on a cruise ship, two CDC doctors say the risk to the public remains low.
Officials say $1.3 billion in Medicaid money to California will be deferred…
Vice President JD Vance announced a $1.3 billion deferral in Medicaid reimbursements to California, as part of an initiative to…
The hantavirus is a wake-up call. Will the Trump administration answer it?
Arriving in the isolation ward of a biocontainment hospital is an unsettling, scary experience. In 2014, I spent 19 days in one…
The ‘velocity of obesity’ aims to show which nations are slowing an epidemic
A study finds the rise in U.S. obesity rates have hit a plateau in children but are still climbing for adults, and are still high…
New subpoena suggests DOJ has begun criminal investigation of gender-affirming…
Several hospitals have received federal grand jury subpoenas regarding gender-affirming care for minors, suggesting a criminal…
Gene therapy viruses linked to a boy's tumor
The case for Makary as the WOAT, Cassidy's seat at risk ahead of midterms, and other biotech news from The Readout
Extreme heat is worsening faster for Black Americans
Bill Cassidy's can't-win conundrum, what RFK Jr. gets right and wrong about antidepressants, and more health news
Scientists link boy’s tumor to gene therapy viruses, in rare finding
Doctors have linked a boy's tumor to a gene therapy, but say the rare risks need to be weighed against the profound benefits such…
Bill Cassidy risked his legacy. It may not be enough to save his career
Sen. Bill Cassidy risked his legacy. It may not be enough to save his career.
RFK Jr.’s antidepressant deprescribing push gets one thing right — and others…
“Deprescribing requires gradual tapering, psychological support, careful risk stratification, and accessible alternatives — none…
A new kind of liver crisis is emerging in the U.S. The American diet is to blame
Young people and women are particularly vulnerable to MetALD, a dangerous merging of metabolic disease and alcohol use.
Access to air conditioning is critical preventive care. But federal policy…
Access to air conditioning is critical preventive care. But federal policy treats it as optional, write Charles E. Leonard and…
Why Marty Makary was the worst FDA commissioner in 25 years
Marty Makary, who resigned under pressure from the FDA, brought to the job a fundamental lack of understanding of the nature of…
Males who discuss suicide seek help less often than females, report finds
Out of 1.5 million messages received in 2025, the Crisis Text Line found that less then 20% of the texters identified as male only
Makary departs FDA amid turmoil as Diamantas, agency's top food official, steps…
Food and Drug Administration Commissioner Marty Makary is resigning from his role after a tumultuous tenure.
Supreme Court extends mifepristone deadline
The deadliest drug in the country, the new name for PCOS, and more health news from Morning Rounds
Hims' sales miss as telehealth competition grows
Bristol's partnership with Hengrui Pharma, Viiv loses HIV treatment case, and more biotech news from The Readout
STAT examines America’s deadliest drug
STAT examines America's failure to address excessive alcohol use across decades.
Capsida says it still doesn’t know what caused gene therapy death
Some in the gene therapy field lament lost time while Capsida kept silent about the brain receptor it was targeting when things…
PCOS’s new name is PMOS, a small letter change that required a big scientific…
A revised name for PCOS — polyendocrine metabolic ovarian syndrome, or PMOS — was introduced in a paper published Tuesday.
Despite its toll, alcohol is still an awkward subject in the doctor’s office
Alcohol screening and counseling are too often compressed or skipped during doctor's visits — a gap that is costing patients and…
6 takeaways from STAT’s investigation into the U.S. alcohol epidemic
Alcohol is the culprit behind the United States' most enduring and overlooked drug crisis. Here are 6 takeaways from STAT's new…
Patients jockey for exemptions from Medicaid’s new work requirements
Advocates for people with HIV and sickle cell disease are among those pushing for exemptions from Medicaid’s new work…
Supreme Court temporarily extends women's access to a widely used abortion pill
The Supreme Court is temporarily extending access to a widely used abortion pill while it considers whether to allow restrictions…
Trump pivots on kratom derivative 7-OH, floating approval for some forms
Last year, the FDA had warned that natural opioids in kratom were being turned into harmful products. Now President Trump says…
The connection between periods and mental health
Plans to oust Makary, a looming Supreme Court deadline on mifepristone, and other health news from Morning Rounds
Animal skin disease confirmed in clusters of European men who have sex with men
European researchers have diagnosed a number of men who have sex with other men with a skin disease that normally infects…
Medicare is spending far less than expected on new Alzheimer’s drugs
Adoption has been slow with new Alzheimer’s drugs because the treatments are complicated to administer and the benefits are…
Experts wonder 'Where is the CDC?' as hantavirus outbreak unfolds
The CDC is playing an unusually small, and quiet, role in responding to the hantavirus outbreak.
Spain readies for evacuations as a hantavirus-hit cruise ship heads for the…
Spanish authorities on Friday were preparing to receive more than 140 passengers and crew members on board a hantavirus-stricken…
Former FDA leaders, pharma speak out on mifepristone
“The fundamental question is: Who gets to regulate mifepristone?”
The biotechs wear Prada
Was Naomi Osaka's Met Gala outfit inspired by Gilead's logo? Janelle Monáe's by Insilico's? Probably not — and yet.
The biotech news you need to read today
A Duchenne therapy lawsuit, FDA Commissioner Marty Makary’s White House troubles, and other news from The Readout
The aging scientific workforce collides with rising fabricating citations in…
The latest in the hantavirus cruise ship saga, why these former officials left the FDA, and more health news from Morning Rounds
Key takeaways from WHO briefing on hantavirus cruise ship outbreak
Here are key takeaways from a WHO briefing on the hantavirus outbreak aboard a cruise ship.
Official leading CDC’s cruise ship program retires
The hantavirus outbreak on the MV Hondius has focused the public's attention on cruise ship safety.
FDA to reconsider treatment for rare cancer after its surprise rejection
The companies developing Ebvallo reached an agreement with the FDA to address its main reason for rejecting the drug.
Color me skeptical: Drinking gold is not an ALS cure
In this week's Biotech Scorecard newsletter, Adam Feuerstein takes on the company touting gold microdust suspended in water as an…
Angelini Pharma buys Catalyst Pharmaceuticals and its rare disease drugs for…
The Italian firm Angelini Pharma is buying Catalyst Pharmaceuticals, the maker of rare disease drugs, for $4.1 billion.